✦ LIBER ✦

Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidaemic drugs to liver homogenates

✍ Scribed by Mark N. Milton; Cliff R. ElcombeP; George E.N. Kass; G.Gordon Gibson

Book ID: 115780192
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 629 KB
Volume: 37
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(88)90163-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liver Peroxisome Proliferator-activated

Liver Peroxisome Proliferator-activated Receptor Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass

✍ Gavrilova, O.; Haluzik, M.; Matsusue, K.; Cutson, J. J.; Johnson, L.; Dietz, K. 📂 Article 📅 2003 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 907 KB

A new mechanism of action for skin white

A new mechanism of action for skin whitening agents: binding to the peroxisome proliferator-activated receptor

✍ J. W. Wiechers; A. V. Rawlings; C. Garcia; C. Chesné; P. Balaguer; J. C. Nicolas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Whomsoever ignores the natural history o

Whomsoever ignores the natural history of the hepatitis C virus is doomed to treat it: Barrett S, Gob J, Cougb1an B, Ryan E, Stewart S, Cockram A, O'Keane JC, Crowe J (Centre for Liver Diseases and Department of Pathology, Mater Misericordiae Hospital, Dublin, Ireland). The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001;49:423–430.

✍ Stephen D. Zucker 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 254 KB